Screening for Lung Cancer with Low-Dose CT — Translating Science into Medicare Coverage Policy

Thanks to recent evidence that screening with low-dose computed tomography reduces lung-cancer mortality, at-risk U.S. patients 55 to 77 years of age are now eligible for a screening benefit under Medicare, while further data are collected and assessed.